Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

US Patent 8389688 · Granted Mar 5, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antibodies for treatment of amyloid deposition diseases2022
Humanized anti-AXL antibodies2021
Network fieldbus power supply2019
Power supply2018
Humanized anti-Tn-MUC1 antibodies and their conjugates2018
Hepatitis C virus antibodies2015
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplan2014
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplan2014
Humanized antibody compositions and methods for binding lysophosphatidic acid2013
Power supply switching and discontinuous power supply mode2013
Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-42012
Humanized antibodies and compositions for binding sphingosine-1-phosphate2012